Shares of Exact Sciences Corp. jumped after Abbott Laboratories announced a deal to acquire the cancer screening test maker ...

We recently published 10 Firms Shining Bright in a Bleeding Market. Jazz Pharmaceuticals plc (NASDAQ:JAZZ) is one of the best ...

Olema Pharmaceuticals stock surged 197% after Roche reported positive trial results for a similar breast cancer drug.

This press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, ...

Jazz Pharmaceuticals plc stock jumped on positive Ziihera trial results. Click for my updated look at JAZZ stock and see why ...

Roche posts positive phase 3 results for giredestrant in early breast cancer, showing improved disease-free survival and a ...

Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies ...

Olema Pharmaceuticals (OLMA) surges after Roche's breast cancer data, but caution is urged as key clinical results are ...

In connection with the proposed offering, Olema expects to grant the underwriters a 30-day option to purchase up to an additional 15% of the total number of shares of common stock Olema is offering ...

Jazz Pharmaceuticals Plc (NASDAQ:JAZZ) shares are popping on Monday following the company's positive results of its Phase 3 HERIZON-GEA-01 trial, which assessed Ziihera in combination with ...

Investing.com -- Jazz Pharmaceuticals (NASDAQ:JAZZ) stock surged 25% after the company announced positive Phase 3 trial results for its cancer drug Ziihera in treating gastroesophageal cancer.

Olema Pharmaceuticals, which trades on the Nasdaq under the ticker OLMA, is working to advance treatments for breast cancer through its development pipeline. The stock’s after-hours decline reflects ...